Clonal sequence tracking reveals -mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus.
作者信息
Yuan Chang-Tsu, Huang Tai-Chung, Chuang Chi-Chen, Chuang Yi-Kuang, Tsai Jia-Huei, Liau Jau-Yu, Lin Chung-Wu, Tang Jih-Luh
机构信息
Department of Pathology, National Taiwan University Hospital.
Department of Pathology, National Taiwan University Cancer Center.
出版信息
Haematologica. 2019 Oct;104(10):e489-e492. doi: 10.3324/haematol.2018.215327. Epub 2019 May 16.
Abstract
摘要
相似文献
1
Clonal sequence tracking reveals -mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus.
Haematologica. 2019 Oct;104(10):e489-e492. doi: 10.3324/haematol.2018.215327. Epub 2019 May 16.
2
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.
Haematologica. 2018 Feb;103(2):278-287. doi: 10.3324/haematol.2017.180430. Epub 2017 Nov 2.
3
Somatic mutations in and associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.
Cancer Biol Ther. 2019;20(10):1319-1327. doi: 10.1080/15384047.2019.1638670. Epub 2019 Jul 16.
4
A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Pediatr Dev Pathol. 2008 Jan-Feb;11(1):50-4. doi: 10.2350/06-07-0140.1.
5
Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Oncologist. 2019 Sep;24(9):e905-e913. doi: 10.1634/theoncologist.2017-0588. Epub 2019 Apr 2.
6
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
Leukemia. 2019 Jul;33(7):1687-1699. doi: 10.1038/s41375-019-0380-5. Epub 2019 Jan 25.
7
TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Oncotarget. 2016 Dec 6;7(49):81512-81526. doi: 10.18632/oncotarget.13130.
8
Nasopharyngeal extranodal NK/T-cell lymphoma, nasal type: retrospective study of 18 consecutive cases in Guangzhou, China.
Int J Surg Pathol. 2011 Feb;19(1):51-61. doi: 10.1177/1066896910388806. Epub 2010 Dec 6.
9
Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.01987-16. Print 2017 Mar 1.
10
Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
Pol J Pathol. 2015 Jun;66(2):161-9. doi: 10.5114/pjp.2015.53013.
引用本文的文献
1
In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas.
Front Oncol. 2023 Feb 10;13:1109715. doi: 10.3389/fonc.2023.1109715. eCollection 2023.
本文引用的文献
1
Emerging epigenetic-modulating therapies in lymphoma.
Nat Rev Clin Oncol. 2019 Aug;16(8):494-507. doi: 10.1038/s41571-019-0190-8.
2
Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
Appl Immunohistochem Mol Morphol. 2019 Mar;27(3):165-173. doi: 10.1097/PAI.0000000000000562.
3
EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
Mod Pathol. 2017 Aug;30(8):1100-1115. doi: 10.1038/modpathol.2017.37. Epub 2017 May 26.
4
Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases.
Front Microbiol. 2017 Mar 1;8:229. doi: 10.3389/fmicb.2017.00229. eCollection 2017.
5
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
Blood. 2017 Apr 27;129(17):2437-2442. doi: 10.1182/blood-2016-12-756841. Epub 2017 Feb 10.
6
EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Am J Surg Pathol. 2017 Jan;41(1):67-74. doi: 10.1097/PAS.0000000000000735.
7
The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Tumour Biol. 2016 Feb;37(2):2037-47. doi: 10.1007/s13277-015-3977-y. Epub 2015 Sep 4.
8
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
Nat Commun. 2015 Jan 14;6:6025. doi: 10.1038/ncomms7025.
9
Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.
Curr Hematol Malig Rep. 2012 Dec;7(4):276-84. doi: 10.1007/s11899-012-0136-z.
10
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
Blood. 2012 Aug 16;120(7):1466-9. doi: 10.1182/blood-2012-02-408542. Epub 2012 Jul 3.
Zotero 插件